These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
101 related items for PubMed ID: 9873709
1. Ligands for the estrogen receptor, containing cyclopentadienyltricarbonylrhenium units. Spradau TW, Katzenellenbogen JA. Bioorg Med Chem Lett; 1998 Nov 17; 8(22):3235-40. PubMed ID: 9873709 [Abstract] [Full Text] [Related]
2. Aryl cyclopentadienyl tricarbonyl rhenium complexes: novel ligands for the estrogen receptor with potential use as estrogen radiopharmaceuticals. Mull ES, Sattigeri VJ, Rodriguez AL, Katzenellenbogen JA. Bioorg Med Chem; 2002 May 17; 10(5):1381-98. PubMed ID: 11886802 [Abstract] [Full Text] [Related]
3. The synthesis of 7 alpha-methyl-substituted estrogens labeled with fluorine-18: potential breast tumor imaging agents. VanBrocklin HF, Liu A, Welch MJ, O'Neil JP, Katzenellenbogen JA. Steroids; 1994 Jan 17; 59(1):34-45. PubMed ID: 8140600 [Abstract] [Full Text] [Related]
4. Novel estradiol based metal complexes of Tc-99m. Neto C, Oliveira MC, Gano L, Marques F, Thiemann T, Santos I. J Inorg Biochem; 2012 Jun 17; 111():1-9. PubMed ID: 22469776 [Abstract] [Full Text] [Related]
5. CoMSIA and docking study of rhenium based estrogen receptor ligand analogs. Wolohan P, Reichert DE. Steroids; 2007 Mar 17; 72(3):247-60. PubMed ID: 17280694 [Abstract] [Full Text] [Related]
6. 16 beta-([18F]fluoro)estrogens: systematic investigation of a new series of fluorine-18-labeled estrogens as potential imaging agents for estrogen-receptor-positive breast tumors. VanBrocklin HF, Carlson KE, Katzenellenbogen JA, Welch MJ. J Med Chem; 1993 May 28; 36(11):1619-29. PubMed ID: 7684451 [Abstract] [Full Text] [Related]
7. Synthesis and binding affinities of new 17 alpha-substituted estradiol-rhenium "n + 1" mixed-ligand and thioether-carbonyl complexes. Wüst F, Carlson KE, Katzenellenbogen JA, Spies H, Johannsen B. Steroids; 1998 Dec 28; 63(12):665-71. PubMed ID: 9870263 [Abstract] [Full Text] [Related]
12. Nonsteroidal bivalent estrogen ligands: an application of the bivalent concept to the estrogen receptor. Shan M, Carlson KE, Bujotzek A, Wellner A, Gust R, Weber M, Katzenellenbogen JA, Haag R. ACS Chem Biol; 2013 Apr 19; 8(4):707-15. PubMed ID: 23312071 [Abstract] [Full Text] [Related]
18. Factors affecting the target site uptake selectivity of estrogen radiopharmaceuticals: serum binding and endogenous estrogens. McElvany KD, Carlson KE, Katzenellenbogen JA, Welch MJ. J Steroid Biochem; 1983 Jun 19; 18(6):635-41. PubMed ID: 6191127 [Abstract] [Full Text] [Related]
19. Prediction of ligand binding affinity and orientation of xenoestrogens to the estrogen receptor by molecular dynamics simulations and the linear interaction energy method. van Lipzig MM, ter Laak AM, Jongejan A, Vermeulen NP, Wamelink M, Geerke D, Meerman JH. J Med Chem; 2004 Feb 12; 47(4):1018-30. PubMed ID: 14761204 [Abstract] [Full Text] [Related]
20. Novel structural templates for estrogen-receptor ligands and prospects for combinatorial synthesis of estrogens. Fink BE, Mortensen DS, Stauffer SR, Aron ZD, Katzenellenbogen JA. Chem Biol; 1999 Apr 12; 6(4):205-19. PubMed ID: 10099132 [Abstract] [Full Text] [Related] Page: [Next] [New Search]